对《绝经后女性骨质疏松症诊断与管理的欧洲指南》的勘误
Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
作者信息
Kanis J A, Cooper C, Rizzoli R, Reginster J-Y
机构信息
Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK.
Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia.
出版信息
Osteoporos Int. 2020 Apr;31(4):801. doi: 10.1007/s00198-020-05303-5.
Abstract
The article [European guidance for the diagnosis and management of osteoporosis in postmenopausal women], written by [J. A. Kanis], was originally published Online First without Open Access.
摘要
由J. A. 卡尼斯撰写的文章《绝经后女性骨质疏松症诊断和管理的欧洲指南》最初以在线优先形式发表，未开放获取。
相似文献
1
Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.对《绝经后女性骨质疏松症诊断与管理的欧洲指南》的勘误
Osteoporos Int. 2020 Apr;31(4):801. doi: 10.1007/s00198-020-05303-5.
2
Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.对《骨质疏松性骨折低、高和极高风险患者的管理算法》的勘误
Osteoporos Int. 2020 Apr;31(4):797-798. doi: 10.1007/s00198-020-05297-0.
3
Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.对《欧洲绝经后女性骨质疏松症诊断和管理指南》的勘误
Osteoporos Int. 2020 Jan;31(1):209. doi: 10.1007/s00198-019-05184-3.
4
Does the presence of postmenopausal symptoms influence susceptibility to vertebral deformity? European Vertebral Osteoporosis Study (EVOS) Group.绝经后症状的出现是否会影响椎体畸形的易感性？欧洲椎体骨质疏松研究（EVOS）小组。
Maturitas. 1999 Aug 16;32(3):179-87. doi: 10.1016/s0378-5122(99)00025-0.
5
Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish Osteoporosis Prevention Study.根据绝经时骨密度T值计算的骨质疏松性骨折的十年绝对风险：丹麦骨质疏松症预防研究
J Bone Miner Res. 2006 May;21(5):796-800. doi: 10.1359/jbmr.020604.
6
7
Correction to: Ubrogepant: First Approval.更正：ubrogepant：首次批准。
Drugs. 2020 Apr;80(5):523. doi: 10.1007/s40265-020-01292-1.
8
Reasons for Not Treating Women with Postmenopausal Osteoporosis with Prescription Medications: Physicians' and Patients' Perspectives.绝经后骨质疏松症女性不使用处方药治疗的原因：医生和患者的观点。
J Womens Health (Larchmt). 2017 Dec;26(12):1302-1311. doi: 10.1089/jwh.2016.6263. Epub 2017 Oct 10.
9
Correction to: Eravacycline: A Review in Complicated Intra-Abdominal Infections.对《依拉环素：复杂性腹腔内感染综述》的勘误
Drugs. 2019 May;79(7):793. doi: 10.1007/s40265-019-01117-w.
10
Correction to: Vestronidase Alfa: A Review in Mucopolysaccharidosis VII.更正：维斯特罗尼酶α：黏多糖贮积症VII的综述。
BioDrugs. 2019 Jun;33(3):343. doi: 10.1007/s40259-019-00353-6.
引用本文的文献
1
Synthetic Data-Enhanced Classification of Prevalent Osteoporotic Fractures Using Dual-Energy X-Ray Absorptiometry-Based Geometric and Material Parameters.基于双能X线吸收法的几何和材料参数的合成数据增强型常见骨质疏松性骨折分类
Endocrinol Metab (Seoul). 2025 Jun;40(3):484-497. doi: 10.3803/EnM.2024.2211. Epub 2025 May 14.
2
Periprosthetic proximal humerus fractures require an individualized treatment approach-results of a multicenter retrospective study.人工肱骨头假体周围近端骨折需要个体化治疗方法-多中心回顾性研究的结果。
Eur J Trauma Emerg Surg. 2024 Aug;50(4):1921-1928. doi: 10.1007/s00068-024-02553-4. Epub 2024 May 28.
3
Association of the visceral adiposity index with femur bone mineral density and osteoporosis among the U.S. older adults from NHANES 2005-2020: a cross-sectional study.2005-2020 年美国 NHANES 研究中内脏脂肪指数与股骨骨密度和骨质疏松症的关系：一项横断面研究。
Front Endocrinol (Lausanne). 2023 Nov 2;14:1231527. doi: 10.3389/fendo.2023.1231527. eCollection 2023.
4
Development and validation of a fully automated system using deep learning for opportunistic osteoporosis screening using low-dose computed tomography scans.利用深度学习开发并验证一种基于低剂量计算机断层扫描进行机会性骨质疏松症筛查的全自动系统。
Quant Imaging Med Surg. 2023 Aug 1;13(8):5294-5305. doi: 10.21037/qims-22-1438. Epub 2023 Jul 20.
5
Efficacy and Mechanisms of Oleuropein in Postmenopausal Osteoporosis.橄榄苦苷治疗绝经后骨质疏松症的疗效及机制。
Comput Math Methods Med. 2022 Aug 25;2022:9767113. doi: 10.1155/2022/9767113. eCollection 2022.
6
The Potential Mechanism of Exercise Combined with Natural Extracts to Prevent and Treat Postmenopausal Osteoporosis.运动联合天然提取物防治绝经后骨质疏松症的潜在机制。
J Healthc Eng. 2021 Dec 17;2021:2852661. doi: 10.1155/2021/2852661. eCollection 2021.
7
Calycosin-7-O-β-Glucoside Isolated from Promotes Osteogenesis and Mineralization in Human Mesenchymal Stem Cells.毛蕊异黄酮-7-O-β-葡萄糖苷促进人骨髓间充质干细胞的成骨和矿化。
Int J Mol Sci. 2021 Oct 21;22(21):11362. doi: 10.3390/ijms222111362.
8
Blood factors as biomarkers in osteoporosis: points from the COVID-19 era.骨质疏松症的血液标志物：来自 COVID-19 时代的观点。
Trends Endocrinol Metab. 2021 Sep;32(9):672-679. doi: 10.1016/j.tem.2021.05.005. Epub 2021 Jul 7.
9
Biological Mechanisms of Paeonoside in the Differentiation of Pre-Osteoblasts and the Formation of Mineralized Nodules.丹皮苷促进前成骨细胞分化及矿化结节形成的生物学机制。
Int J Mol Sci. 2021 Jun 27;22(13):6899. doi: 10.3390/ijms22136899.
10
The development of a reliable and valid instrument to measure the osteoporosis-related knowledge: validation of the Hungarian version of Osteoporosis Knowledge Assessment Tool (OKAT).研制一种可靠且有效的骨质疏松症相关知识测量工具：验证骨质疏松症知识评估工具（OKAT）匈牙利语版本的有效性。
BMC Public Health. 2021 Apr 23;21(Suppl 1):1515. doi: 10.1186/s12889-020-09565-w.
Zotero 插件